A US study found a significantly higher cost of care associated with cirrhosis vs with heart failure or chronic obstructive pulmonary disease.

Despite the approval of second-generation antiobesity medications, metabolic and bariatric surgery among US adolescents increased from 2021 to 2023.

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

Some of the nation's top brain researchers are facing layoffs, even after HHS Secretary RFK Jr said no working scientists would be cut.

For patients with immune-mediated inflammatory diseases, CVD mortality decreased from 1999 to 2020, but sex disparities ...

Topline data were announced from a phase 3 trial evaluating olezarsen in patients with moderate hypertriglyceridemia with or at risk for ASCVD.

A study has found that, up to 1 year postpartum, prenatal psychosocial factors may impact the cardiovascular health of mothers.

Gender-affirming hormone therapy was associated with a significant reduction in moderate to severe depression among TGD adults in the US.

AI tools are effective for detecting left ventricular systolic dysfunction among women of reproductive age seen in primary care.

Inhaled insulin was noninferior to usual care in glycemic control outcomes after 17 weeks among patients with type 1 diabetes.

Between 1999 and 2019 in the US, deaths related to hypertrophic cardiomyopathy decreased, but then significantly increased during the COVID-19 pandemic.

The FDA has approved Optison for use in pediatric patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricle endocardial borders.